Search Results - "Sanche, Steve"
-
1
Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?
Published in Clinical infectious diseases (02-08-2021)“…Abstract Background Noninvasive markers of liver fibrosis such as aspartate aminotransferase-to-platelet ratio (APRI) and transient elastography (TE) have…”
Get full text
Journal Article -
2
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus
Published in Clinical infectious diseases (11-07-2020)“…Abstract Background High costs of direct-acting antivirals (DAAs) have led health-care insurers to limit access worldwide. Using a natural experiment, we…”
Get full text
Journal Article -
3
Trends in cause-specific mortality in HIV–hepatitis C coinfection following hepatitis C treatment scale-up
Published in AIDS (London) (01-05-2019)“…OBJECTIVE:Hepatitis C virus (HCV) treatment may reduce liver-related mortality but with competing risks, other causes of mortality may undermine benefits. We…”
Get full text
Journal Article -
4
Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada
Published in Clinical infectious diseases (08-02-2023)“…Depression is common in people with human immunodeficiency virus (HIV) and hepatitis C virus (HCV), with biological and psychosocial mechanisms at play. Direct…”
Get full text
Journal Article -
5
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)
Published in International journal of epidemiology (01-02-2024)Get full text
Journal Article -
6
Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada
Published in PloS one (19-04-2021)“…HIV-HCV coinfected individuals are often more deprived than the general population. However, deprivation is difficult to measure, often relying on aggregate…”
Get full text
Journal Article -
7
Real‐world impact of direct acting antiviral therapy on health‐related quality of life in HIV/Hepatitis C co‐infected individuals
Published in Journal of viral hepatitis (01-12-2018)“…Summary Clinical trial results of direct acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV) have shown improvements in health‐related…”
Get full text
Journal Article -
8
Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning
Published in BMC medical research methodology (12-08-2022)“…Abstract Background Depression is common in the human immunodeficiency virus (HIV)-hepatitis C virus (HCV) co-infected population. Demographic, behavioural,…”
Get full text
Journal Article -
9
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals
Published in The International journal of drug policy (01-03-2019)“…Patients co-infected with HIV and hepatitis C virus (HCV) are a priority target for HCV treatment. The simplicity and efficacy of direct-acting antivirals…”
Get full text
Journal Article -
10
Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons
Published in Clinical infectious diseases (15-01-2016)“…Background. Liver diseases progress faster in human immunodeficiency virus (HIV)–hepatitis C virus (HCV)-coinfected persons than HIV-monoinfected persons. The…”
Get full text
Journal Article -
11
Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study
Published in BMC infectious diseases (17-01-2017)“…Cocaine and crack use has been associated with HIV and HCV infections, but its consequences on HCV progression have not been well established. We analyzed the…”
Get full text
Journal Article -
12
Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV–Coinfected Patients in Clinical Care
Published in Open forum infectious diseases (01-03-2019)“…Abstract Background There are limited data on the real-world effectiveness of direct-acting antiviral (DAA) treatment in patients coinfected with hepatitis C…”
Get full text
Journal Article -
13
Opioid use and risk of liver fibrosis in HIV/hepatitis C virus‐coinfected patients in Canada
Published in HIV medicine (01-01-2016)“…Objectives Opioid use and opioid‐related mortality have increased dramatically since the 1990s in North America. The effect of opioids on the liver is…”
Get full text
Journal Article -
14
Fibroblast growth factor 23: associations with antiretroviral therapy in patients co‐infected with HIV and hepatitis C
Published in HIV medicine (01-05-2016)“…Objectives Fibroblast growth factor 23 (FGF23) has been associated with cardiovascular mortality. We estimate associations between the level of plasma FGF23…”
Get full text
Journal Article -
15
Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals
Published in International journal of molecular sciences (20-03-2015)“…Canadian Aboriginals are reported to clear Hepatitis C (HCV) more frequently. We tested the association of spontaneous clearance and three single nucleotide…”
Get full text
Journal Article -
16
A Portrait of Electronic Medical Record Use in Primary Care Across Canada
Published in Health reform observer (01-06-2016)Get full text
Journal Article